[Therapy of erythroleukemia].
D003561:Cytarabine / Q000627:therapeutic use; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014805:Vitamin B 12 / Q000627:therapeutic use
D003561:Cytarabine; D005492:Folic Acid; D015122:Mercaptopurine; D011736:Pyridoxine; D014805:Vitamin B 12; D011241:Prednisone; D008727:Methotrexate
La terapia delle eritroleucemie.